Understanding and management of male breast cancer: a critical review.
Breast cancer is a rare disease in men representing nearly 1% of the total breast cancer cases worldwide. While treatments developed for women with breast cancer are often applied to treat men with breast cancer, however, lack of awareness of this disease leads to its detection at a later stage in men. This review discusses male breast cancer and draws comparisons with female breast cancer and discusses current treatments available to treat this disease. It is believed that this review shall provide concise and relevant information increasing the awareness of issues revolving around male breast cancer (MBC).
Pant
Kartikeya
K
Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA. kpant@mit.edu
Dutta
Udayan
U
D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D047072:Aromatase Inhibitors / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000453:epidemiology / Q000378:metabolism / Q000401:mortality / Q000628:therapy*; D018567:Breast Neoplasms, Male / Q000453:epidemiology* / Q000378:metabolism / Q000523:psychology / Q000628:therapy*; D017024:Chemotherapy, Adjuvant; D004967:Estrogens / Q000378:metabolism; D005260:Female; D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D012727:Sex Characteristics; D013629:Tamoxifen / Q000627:therapeutic use
D018931:Antineoplastic Agents, Hormonal; D047072:Aromatase Inhibitors; D004967:Estrogens; D013629:Tamoxifen